lifestyle.capitolhilltimes.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Immix Biopharma, Inc.
Immix Biopharma to Participate in the Jefferies Global Healthcare Conference
April 9, 2026
Immix Biopharma Announces Enrollment Completion of BLA-Enabling Relapsed/Refractory AL Amyloidosis Trial NEXICART-2, and Upcoming Milestones
March 30, 2026
Immix Biopharma to Participate in Upcoming Investor Conferences
March 3, 2026
Immix Biopharma Receives U.S. FDA Breakthrough Therapy Designation for NXC-201
January 28, 2026